The Company is a Korea-based company mainly engaged in manufacturing products related to life science medicine. The Company mainly develops and sells target capture kit products. In addition, the Company is engaged in immune repertoire analysis solutions and next-generation sequencing solutions. The Company sells its products in domestic and overseas markets. The Company was established on November 29, 2010. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on August 21, 2020.
Headquarters
19F ~ 20F, Bldg. A, Byc Highcity, 131, Gasandigital 1-Ro, Geumcheon-Gu
Seoul; Seoul;
Contact Details: Purchase the Celemics, Inc. report to view the information.
Website: http://www.celemics.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service